A detailed history of Northwest & Ethical Investments L.P. transactions in Profound Medical Corp. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 23,700 shares of PROF stock, worth $194,339. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,700
Holding current value
$194,339
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.25 - $9.07 $171,825 - $214,959
23,700 New
23,700 $203 Million

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $171M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.